1 year return (CAGR)
288.30%
Inhibrx Biosciences, Inc. Exchange (NASDAQ, USD)
INBX
110.47
+1.20 (+1.10%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
72.42%
5 year return (CAGR)
28.61%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.63B
Price/Sales
-
Ent value
1.70B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
24.58%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 109.10 |
| Daily high | 111.44 |
| Daily low | 104.90 |
| Daily Volume | 240K |
| All-time high | 141.84 |
| 1y analyst estimate | 266.67 |
| Beta | 3.52 |
| EPS (TTM) | -8.82 |
| Dividend per share | 0.00 |
| Ex-div date | 30 May 2024 |
| Next earnings date | 23 Mar 2026 |
Downside potential
Loading...
Downside potential data
| INBX | S&P500 | |
| Current price drop from All-time high | -22.12% | -2.19% |
| Highest price drop | -82.96% | -56.47% |
| Date of highest drop | 14 Jun 2022 | 9 Mar 2009 |
| Avg drop from high | -45.69% | -10.68% |
| Avg time to new high | 42 days | 12 days |
| Max time to new high | 1218 days | 1805 days |
News
